Zeynep Meric
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zeynep Meric has a total of 171 co-authors. Here are the top co-authors by number of shared publications:
- Ayca Kiykim
Department of Pediatric Allergy and Immunology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
10 shared publications - Esra Yucel
Cerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology Istanbul University‐Cerrahpasa Istanbul Turkiye
8 shared publications - Betul Gemici Karaaslan
Cerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology Istanbul University‐Cerrahpasa Istanbul Turkiye
7 shared publications - Sezin Aydemir
Department of Pediatric Allergy and Immunology, İstanbul Medeniyet University Faculty of Medicine Göztepe Prof. Dr. Süleyman Yalçın City Hospital Istanbul Turkey
7 shared publications Ayca Kiykim
Cerrahpasa Faculty of Medicine, Department of Pediatrics, Division of Pediatric Immunology and Allergy Istanbul University‐Cerrahpasa Istanbul Turkiye
5 shared publications- Haluk Cokugras
Department of Pediatric Allergy and Immunology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
5 shared publications
Latest Publications
- 2 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
When cure is not enough: Parental anxiety, depression, and caregiver burden after HSCT for inborn errors of immunity
Introduction: Hematopoietic stem cell transplantation (HSCT) is curative for many children with inborn errors of immunity (IEIs). While research has largely focused on survival, immune reconstitution, and transplant‐related complications, the long‐term psychosocial impact on families of medically stable, complication‐free survivors remains poorly understood. Methods: In this cross‐sectional case–control study, 79 children with IEIs who achieved full immune reconstitution after HSCT and were free of chronic disease‐ or transplant‐related complications were compared with 69 age‐ and sex‐matched healthy controls. Parents completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Zarit Burden Interview (ZBI). Caregivers also completed the parent‐report Strengths and Difficulties Questionnaire (SDQ). Linear regression analysis was performed to identify factors associated with caregiver burden. Results: Mothers of transplanted children had significantly higher depression, anxiety, and caregiver burden scores than control mothers (all p ≤ .001). Fathers demonstrated higher depression scores, whereas anxiety scores did not differ significantly. Maternal depression independently predicted caregiver burden ( β = .913, 95% CI 0.512–1.314, p < .001). Children in the patient group showed higher conduct problem and hyperactivity scores, with a trend toward greater internalizing difficulties. Psychological outcomes were not associated with demographic characteristics, disease‐related factors, or time since transplantation. Discussion: Despite successful immune reconstitution and the absence of chronic complications, families continued to experience substantial psychosocial burden. Maternal depressive symptoms emerged as the strongest determinant of caregiver burden. These findings suggest that medical recovery after HSCT does not necessarily translate into psychosocial recovery and support the integration of routine family‐centered psychological assessment into long‐term follow‐up care. image
- 2 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
When cure is not enough: Parental anxiety, depression, and caregiver burden after HSCT for inborn errors of immunity
Introduction: Hematopoietic stem cell transplantation (HSCT) is curative for many children with inborn errors of immunity (IEIs). While research has largely focused on survival, immune reconstitution, and transplant‐related complications, the long‐term psychosocial impact on families of medically stable, complication‐free survivors remains poorly understood. Methods: In this cross‐sectional case–control study, 79 children with IEIs who achieved full immune reconstitution after HSCT and were free of chronic disease‐ or transplant‐related complications were compared with 69 age‐ and sex‐matched healthy controls. Parents completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Zarit Burden Interview (ZBI). Caregivers also completed the parent‐report Strengths and Difficulties Questionnaire (SDQ). Linear regression analysis was performed to identify factors associated with caregiver burden. Results: Mothers of transplanted children had significantly higher depression, anxiety, and caregiver burden scores than control mothers (all p ≤ .001). Fathers demonstrated higher depression scores, whereas anxiety scores did not differ significantly. Maternal depression independently predicted caregiver burden ( β = .913, 95% CI 0.512–1.314, p < .001). Children in the patient group showed higher conduct problem and hyperactivity scores, with a trend toward greater internalizing difficulties. Psychological outcomes were not associated with demographic characteristics, disease‐related factors, or time since transplantation. Discussion: Despite successful immune reconstitution and the absence of chronic complications, families continued to experience substantial psychosocial burden. Maternal depressive symptoms emerged as the strongest determinant of caregiver burden. These findings suggest that medical recovery after HSCT does not necessarily translate into psychosocial recovery and support the integration of routine family‐centered psychological assessment into long‐term follow‐up care. image
- 22 October 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (10)
Clinical characteristics, recurrence patterns, and re‐transfusion outcomes of allergic transfusion reactions in children: A 10‐year cohort study
Background: Allergic transfusion reactions (ATRs) are among the most common adverse events associated with blood transfusion in children. However, data regarding recurrent ATRs, transfusion‐associated anaphylaxis, and their clinical outcomes remain limited. We aimed to investigate the incidence, clinical characteristics, recurrence patterns, and potential risk factors for ATRs in pediatric patients. Methods: This retrospective observational study included pediatric patients who developed ATRs at a tertiary referral center between August 2016 and August 2026. Clinical records, transfusion characteristics, laboratory findings, management strategies, and follow‐up data were reviewed. Recurrent ATRs were evaluated only among patients who underwent repeated transfusions. Comparisons between groups were performed using exact non‐parametric statistical methods. Results: Among 37,496 transfusions, 69 ATR episodes occurred in 47 patients, corresponding to an overall incidence of 0.18%. Platelet concentrates were associated with the highest ATR rate (0.51%), followed by fresh frozen plasma (0.15%) and erythrocyte suspensions (0.09%). Mucocutaneous manifestations predominated, whereas transfusion‐associated anaphylaxis occurred in 9 episodes (13%), corresponding to 24 per 100,000 transfusions. Among 37 patients who underwent repeated transfusions, recurrent ATRs occurred in 13 (35%). No significant associations were identified between recurrent ATRs and the type of blood component, history of allergic disease, elevated total IgE levels, or the severity of the index reaction. Premedication before the index ATR did not differ significantly between patients with and without recurrent ATRs. Importantly, no patient experienced recurrent anaphylaxis during follow‐up; subsequent transfusions were either well tolerated or associated only with mild cutaneous manifestations. Conclusion: ATRs in children encompass a broad clinical spectrum ranging from mild cutaneous reactions to anaphylaxis. Recurrent ATRs are common among children requiring repeated transfusions, but reliable clinical predictors of recurrence were not identified. Our findings suggest that continued transfusion therapy may be feasible with careful clinical monitoring and an individualized management approach. image
- 22 October 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (10)
Clinical characteristics, recurrence patterns, and re‐transfusion outcomes of allergic transfusion reactions in children: A 10‐year cohort study
Background: Allergic transfusion reactions (ATRs) are among the most common adverse events associated with blood transfusion in children. However, data regarding recurrent ATRs, transfusion‐associated anaphylaxis, and their clinical outcomes remain limited. We aimed to investigate the incidence, clinical characteristics, recurrence patterns, and potential risk factors for ATRs in pediatric patients. Methods: This retrospective observational study included pediatric patients who developed ATRs at a tertiary referral center between August 2016 and August 2026. Clinical records, transfusion characteristics, laboratory findings, management strategies, and follow‐up data were reviewed. Recurrent ATRs were evaluated only among patients who underwent repeated transfusions. Comparisons between groups were performed using exact non‐parametric statistical methods. Results: Among 37,496 transfusions, 69 ATR episodes occurred in 47 patients, corresponding to an overall incidence of 0.18%. Platelet concentrates were associated with the highest ATR rate (0.51%), followed by fresh frozen plasma (0.15%) and erythrocyte suspensions (0.09%). Mucocutaneous manifestations predominated, whereas transfusion‐associated anaphylaxis occurred in 9 episodes (13%), corresponding to 24 per 100,000 transfusions. Among 37 patients who underwent repeated transfusions, recurrent ATRs occurred in 13 (35%). No significant associations were identified between recurrent ATRs and the type of blood component, history of allergic disease, elevated total IgE levels, or the severity of the index reaction. Premedication before the index ATR did not differ significantly between patients with and without recurrent ATRs. Importantly, no patient experienced recurrent anaphylaxis during follow‐up; subsequent transfusions were either well tolerated or associated only with mild cutaneous manifestations. Conclusion: ATRs in children encompass a broad clinical spectrum ranging from mild cutaneous reactions to anaphylaxis. Recurrent ATRs are common among children requiring repeated transfusions, but reliable clinical predictors of recurrence were not identified. Our findings suggest that continued transfusion therapy may be feasible with careful clinical monitoring and an individualized management approach. image
- 9 July 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 104 (1) , e70139
Dupilumab in Severe Atopic Dermatitis With Phosphoglucomutase 3 Deficiency
- 9 July 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 104 (1) , e70139
Dupilumab in Severe Atopic Dermatitis With Phosphoglucomutase 3 Deficiency
- Open Access
- 13 June 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 2923-2930
Beyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation
Introduction: Hematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood. Methods: Children aged 8–18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children’s Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls. Results: Thirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments. Conclusion: Despite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.
- 13 June 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 2923-2930
Open AccessBeyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation
Introduction: Hematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood. Methods: Children aged 8–18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children’s Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls. Results: Thirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments. Conclusion: Despite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.
- Open Access
- 31 May 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (6) , e70379
PECU: A multicenter study on pediatric patients with cold‐induced urticaria
Background: Cold‐induced urticaria (ColdU) is a rare chronic inducible urticaria that can cause systemic reactions, including cold‐induced anaphylaxis (ColdA), but pediatric data are limited. The aim of this study was to evaluate the clinical characteristics, comorbidities, management approaches, risk of anaphylaxis, and long‐term course of ColdU in a pediatric cohort, and to identify risk factors for ColdA, determinants of disease resolution, and predictors of persistence into adulthood. Methods: This retrospective multicenter study included 203 pediatric patients with ColdU across 30 centers in Türkiye. Clinical characteristics and management of patients were analyzed. Logistic regression was used to identify factors associated with ColdA and disease resolution. Results: The median age at diagnosis was 14.3 years, and the median age at onset was 10 years; 56.1% of patients were female. ColdA occurred in 17.2%, with increased risk associated with male sex, autoimmune comorbidities, older age, and triggering by cold food/beverage ingestion. Most patients (82.2%) received second‐generation H1‐antihistamines; omalizumab achieved >90% symptom control in 12 refractory cases. Over a median 3.5‐year follow‐up, 30.5% achieved disease resolution (median duration: 18 months). The history of anaphylaxis and comorbid atopy significantly reduced the likelihood of remission. Some patients showed adult persistence, without clear predictors. Discussion: ColdA may occur even without classic high‐risk features; pediatric ColdU management should be guided by individualized risk assessment, prioritizing clinical risk factors—such as older age, high‐risk cold triggers, angioedema, and autoimmune comorbidities—over isolated diagnostic parameters. In refractory cases, omalizumab is an effective and well‐tolerated option. Prior anaphylaxis and comorbid allergic disease predicted poorer remission.
- 31 May 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (6) , e70379
Open AccessPECU: A multicenter study on pediatric patients with cold‐induced urticaria
Background: Cold‐induced urticaria (ColdU) is a rare chronic inducible urticaria that can cause systemic reactions, including cold‐induced anaphylaxis (ColdA), but pediatric data are limited. The aim of this study was to evaluate the clinical characteristics, comorbidities, management approaches, risk of anaphylaxis, and long‐term course of ColdU in a pediatric cohort, and to identify risk factors for ColdA, determinants of disease resolution, and predictors of persistence into adulthood. Methods: This retrospective multicenter study included 203 pediatric patients with ColdU across 30 centers in Türkiye. Clinical characteristics and management of patients were analyzed. Logistic regression was used to identify factors associated with ColdA and disease resolution. Results: The median age at diagnosis was 14.3 years, and the median age at onset was 10 years; 56.1% of patients were female. ColdA occurred in 17.2%, with increased risk associated with male sex, autoimmune comorbidities, older age, and triggering by cold food/beverage ingestion. Most patients (82.2%) received second‐generation H1‐antihistamines; omalizumab achieved >90% symptom control in 12 refractory cases. Over a median 3.5‐year follow‐up, 30.5% achieved disease resolution (median duration: 18 months). The history of anaphylaxis and comorbid atopy significantly reduced the likelihood of remission. Some patients showed adult persistence, without clear predictors. Discussion: ColdA may occur even without classic high‐risk features; pediatric ColdU management should be guided by individualized risk assessment, prioritizing clinical risk factors—such as older age, high‐risk cold triggers, angioedema, and autoimmune comorbidities—over isolated diagnostic parameters. In refractory cases, omalizumab is an effective and well‐tolerated option. Prior anaphylaxis and comorbid allergic disease predicted poorer remission.
- Open Access
- 29 March 2026
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 7 (1) , 8-17
Molecular diagnostic success of targeted next-generation sequencing (NGS) in 101 pediatric patients with inborn errors of immunity
Objective: Inborn errors of immunity (IEIs) comprise a genetically heterogeneous group of disorders predisposing individuals to recurrent and severe infections, autoimmunity, and immune dysregulation. Next-generation sequencing (NGS) has greatly improved diagnostic efficiency by allowing simultaneous analysis of multiple genes. This study aimed to evaluate the molecular diagnostic yield and characterize the variant spectrum in patients with suspected IEIs using a targeted NGS panel. Methods: A total of 101 pediatric patients clinically diagnosed with IEIs and referred to the Pediatric Genetics Department Ümraniye Training and Research Hospital between 2018 and 2021 were included in the study. Genetic analysis was performed using a targeted NGS panel encompassing 260 genes associated with IEIs. Variants were interpreted according to American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) and Clinical Genome (ClinGen) Sequence Variant Interpretation (SVI) guidelines. Single-nucleotide variants (SNVs) were confirmed by Sanger sequencing, and copy number variants (CNVs) were validated using array-based comparative genomic hybridization (array-CGH). Results: Pathogenic or likely pathogenic (P/LP) variants were identified in 25 of 101 patients (24.7%), yielding 26 distinct variants across 21 genes, including one patient with two variants in a compound heterozygous state. Among these, 18 were homozygous, 3 heterozygous, 3 hemizygous, and 1 compound heterozygous. The most frequently affected genes were RAG1, DCLRE1C, SPINK5, and STAT1. Three novel variants were identified, expanding the known mutational spectrum of IEIs. In addition, several variants initially identified in this cohort were later reported by our group, highlighting the contribution of our study to the expanding genetic spectrum of IEIs in Türkiye. Most variants exhibited autosomal recessive inheritance, consistent with the high consanguinity rate in the study population. Conclusion: In our IEI cohort, targeted NGS achieved a 24.7% molecular diagnostic yield and successfully identified both known and novel pathogenic variants across a broad spectrum of genes. These findings highlight the diagnostic value of targeted NGS in genetically and clinically heterogeneous conditions such as IEIs and underscore the importance of population-specific variant databases for improving variant interpretation and optimizing patient care.
- 29 March 2026
- Published by Aydin Pediatric Society in Trends in Pediatrics
- Vol. 7 (1) , 8-17
Open AccessMolecular diagnostic success of targeted next-generation sequencing (NGS) in 101 pediatric patients with inborn errors of immunity
Objective: Inborn errors of immunity (IEIs) comprise a genetically heterogeneous group of disorders predisposing individuals to recurrent and severe infections, autoimmunity, and immune dysregulation. Next-generation sequencing (NGS) has greatly improved diagnostic efficiency by allowing simultaneous analysis of multiple genes. This study aimed to evaluate the molecular diagnostic yield and characterize the variant spectrum in patients with suspected IEIs using a targeted NGS panel. Methods: A total of 101 pediatric patients clinically diagnosed with IEIs and referred to the Pediatric Genetics Department Ümraniye Training and Research Hospital between 2018 and 2021 were included in the study. Genetic analysis was performed using a targeted NGS panel encompassing 260 genes associated with IEIs. Variants were interpreted according to American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) and Clinical Genome (ClinGen) Sequence Variant Interpretation (SVI) guidelines. Single-nucleotide variants (SNVs) were confirmed by Sanger sequencing, and copy number variants (CNVs) were validated using array-based comparative genomic hybridization (array-CGH). Results: Pathogenic or likely pathogenic (P/LP) variants were identified in 25 of 101 patients (24.7%), yielding 26 distinct variants across 21 genes, including one patient with two variants in a compound heterozygous state. Among these, 18 were homozygous, 3 heterozygous, 3 hemizygous, and 1 compound heterozygous. The most frequently affected genes were RAG1, DCLRE1C, SPINK5, and STAT1. Three novel variants were identified, expanding the known mutational spectrum of IEIs. In addition, several variants initially identified in this cohort were later reported by our group, highlighting the contribution of our study to the expanding genetic spectrum of IEIs in Türkiye. Most variants exhibited autosomal recessive inheritance, consistent with the high consanguinity rate in the study population. Conclusion: In our IEI cohort, targeted NGS achieved a 24.7% molecular diagnostic yield and successfully identified both known and novel pathogenic variants across a broad spectrum of genes. These findings highlight the diagnostic value of targeted NGS in genetically and clinically heterogeneous conditions such as IEIs and underscore the importance of population-specific variant databases for improving variant interpretation and optimizing patient care.
- 9 March 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (3) , e70318
Vulnerability beyond infection: Effects of peer victimization on quality of life and psychosocial well‐being in inborn errors of immunity
Background: Inborn errors of immunity (IEIs) comprise a heterogeneous group of over 500 genetic disorders characterized by increased susceptibility to infections, autoimmunity, and malignancy. Beyond their biological burden, IEIs may impose substantial psychosocial challenges due to frequent hospitalizations, prolonged treatments, and perceived social differences. Although bullying is a recognized determinant of anxiety, depression, and impaired quality of life (QoL), its impact in children with IEIs remains poorly understood. This study investigated the relationship between peer victimization (PV), psychological symptoms, and QoL among children with IEI. Methods: A case–control study was conducted at the Department of Pediatric Immunology and Allergy, ***University, including children aged 8–18 years with confirmed IEI and healthy controls (HCs) with similar age and sex distribution. Questionnaires were used to evaluate the PV, psychological status, and QOL of children and adolescents with and without IEI. Results: Fifty‐nine patients and sixty‐five HCs (median age 13 years) were enrolled. Predominantly antibody deficiencies represented the most common IEI category (39%). No significant difference was found between the study and HCs for PV, depression state and trait anxiety. Patients demonstrated significantly lower PedsQL school, psychosocial, and total scores compared with HCs ( p = .004, p = .021, p = .018, respectively). Peer victimization correlated negatively with psychosocial health and positively with anxiety and depression scores. Regression analysis identified peers' awareness of the illness, RCADS total score and property‐related victimization as independent predictors of poorer psychosocial outcomes. Conclusion: Children with IEI constitute a psychosocially vulnerable population. Routine psychosocial screening and integrated mental health support are essential for comprehensive care and improved quality of life.
- 9 March 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (3) , e70318
Vulnerability beyond infection: Effects of peer victimization on quality of life and psychosocial well‐being in inborn errors of immunity
Background: Inborn errors of immunity (IEIs) comprise a heterogeneous group of over 500 genetic disorders characterized by increased susceptibility to infections, autoimmunity, and malignancy. Beyond their biological burden, IEIs may impose substantial psychosocial challenges due to frequent hospitalizations, prolonged treatments, and perceived social differences. Although bullying is a recognized determinant of anxiety, depression, and impaired quality of life (QoL), its impact in children with IEIs remains poorly understood. This study investigated the relationship between peer victimization (PV), psychological symptoms, and QoL among children with IEI. Methods: A case–control study was conducted at the Department of Pediatric Immunology and Allergy, ***University, including children aged 8–18 years with confirmed IEI and healthy controls (HCs) with similar age and sex distribution. Questionnaires were used to evaluate the PV, psychological status, and QOL of children and adolescents with and without IEI. Results: Fifty‐nine patients and sixty‐five HCs (median age 13 years) were enrolled. Predominantly antibody deficiencies represented the most common IEI category (39%). No significant difference was found between the study and HCs for PV, depression state and trait anxiety. Patients demonstrated significantly lower PedsQL school, psychosocial, and total scores compared with HCs ( p = .004, p = .021, p = .018, respectively). Peer victimization correlated negatively with psychosocial health and positively with anxiety and depression scores. Regression analysis identified peers' awareness of the illness, RCADS total score and property‐related victimization as independent predictors of poorer psychosocial outcomes. Conclusion: Children with IEI constitute a psychosocially vulnerable population. Routine psychosocial screening and integrated mental health support are essential for comprehensive care and improved quality of life.
- 1 December 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 102 (6) , e70074
Granulomatous and Lymphocytic Interstitial Lung Disease in Hyper‐ IgM Syndrome
- 1 December 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 102 (6) , e70074
Granulomatous and Lymphocytic Interstitial Lung Disease in Hyper‐ IgM Syndrome
- 21 November 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (2) , 464-474.e4
The Skin Tells the Story: Early Signs of Inborn Errors of Immunity
- 21 November 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (2) , 464-474.e4
The Skin Tells the Story: Early Signs of Inborn Errors of Immunity
- 9 November 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 102 (5) , e70063
Expansion of Myeloid‐Derived Suppressor Cells and Lymphocyte Apoptosis Beyond B‐Cell Deficiency in X‐Linked Agammaglobulinemia
X‐linked agammaglobulinemia (XLA) is caused by Bruton tyrosine kinase gene mutations, leading to B‐cell deficiency. This study aimed to investigate myeloid‐derived suppressor cells (MDSCs) frequency, lymphocyte apoptosis and clinical significance in patients with XLA. The study comprised 46 paediatric (mean age: 9.9 ± 4.8 years) and 21 adult patients (24.6 ± 5.9 years). Total MDSCs (HLA‐DR − CD33 + CD11b + ) were subdivided into CD15 + polymorphonuclear (PMN‐MDSCs) and CD14 + monocytic (M‐MDSCs) and analysed by flow cytometry. The paediatric XLA patients had increased M‐MDSCs and early apoptotic lymphocyte frequency compared to healthy subjects. The mean diagnostic delay was positively correlated with early apoptotic CD3 + and CD4 + T‐cells. Seventeen patients (14 adults and 3 children) had bronchiectasis. PMN‐MDSCs were higher in adult patients than in paediatric patients. Increased PMN‐MDSCs in adults with XLA suggest the presence of chronic inflammation in patients with bronchiectasis. The study findings broaden understanding of XLA's complex immunopathology and highlight the need for more comprehensive immune monitoring of these patients beyond antibody production.
- 9 November 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 102 (5) , e70063
Expansion of Myeloid‐Derived Suppressor Cells and Lymphocyte Apoptosis Beyond B‐Cell Deficiency in X‐Linked Agammaglobulinemia
X‐linked agammaglobulinemia (XLA) is caused by Bruton tyrosine kinase gene mutations, leading to B‐cell deficiency. This study aimed to investigate myeloid‐derived suppressor cells (MDSCs) frequency, lymphocyte apoptosis and clinical significance in patients with XLA. The study comprised 46 paediatric (mean age: 9.9 ± 4.8 years) and 21 adult patients (24.6 ± 5.9 years). Total MDSCs (HLA‐DR − CD33 + CD11b + ) were subdivided into CD15 + polymorphonuclear (PMN‐MDSCs) and CD14 + monocytic (M‐MDSCs) and analysed by flow cytometry. The paediatric XLA patients had increased M‐MDSCs and early apoptotic lymphocyte frequency compared to healthy subjects. The mean diagnostic delay was positively correlated with early apoptotic CD3 + and CD4 + T‐cells. Seventeen patients (14 adults and 3 children) had bronchiectasis. PMN‐MDSCs were higher in adult patients than in paediatric patients. Increased PMN‐MDSCs in adults with XLA suggest the presence of chronic inflammation in patients with bronchiectasis. The study findings broaden understanding of XLA's complex immunopathology and highlight the need for more comprehensive immune monitoring of these patients beyond antibody production.